Double-blind, randomised, placebo controlled low level laser therapy study in patients with primary Raynaud's phenomenon.

@article{Hirschl2002DoubleblindRP,
  title={Double-blind, randomised, placebo controlled low level laser therapy study in patients with primary Raynaud's phenomenon.},
  author={Mirko Hirschl and Reinhold Katzenschlager and Kirsten Ammer and P. Melnizky and O. Rathkolb and Michael Kundi},
  journal={VASA. Zeitschrift fur Gefasskrankheiten},
  year={2002},
  volume={31 2},
  pages={91-4}
}
BACKGROUND No causal treatment of primary Raynaud's phenomenon is available due to its unclear aetiology. Low level laser therapy (LLLT) is applied in a multitude of medical conditions often without sufficient evidence of efficacy and established mechanisms. To asses the effect of this therapy in patients with primary Raynaud's phenomenon a randomised, double blind, placebo controlled cross over study was designed. PATIENTS AND METHODS Absolute and relative frequency and intensity of… CONTINUE READING